One-Stop Services: | CRO & CDMO | Technology Brokerage  Licensed Co-Development & China Based Fund Investment Partnership 中文 | English
HOME ABOUT US SERVICES RESOURCES MEDIA CENTRE CLIENTS & PARTNERS CONTACT US
Home » Services » EU and China Clinical study management and local regulatory affairs
 
Services
Europe Technology Transfer & Licence
EU and China R&D Collaboration Project management
Europe and China pre-clinical research management
EU and China Clinical study management and local regulatory affairs
Strategic sourcing and contract manufacturing
China pharmaceutical EU market analysis and strategic business development
China novel drug EU clinical study project management
Chinese pharmaceutical company EU market analysis and strategic business development
Fully Integrated Preclinical CRO Services
UK HQ ADDRESS
Link China Solutions Ltd
Milton Hall
Ely Road, Cambridge
CB24 6WZ
United Kingdom
Phone: 0044(0)122 382 8215
Email: info@chinapharma.co.uk
 

We will provide China and UK clinical trial I-IV local site management services on behalf of our clients requires meticulous planning, efficient project management and excellent communication skills to deal with a variety of cultures and local practices.
LCPS offers a comprehensive clinical trials service in China and UK in both patients and healthy volunteers. LCPS has access to the significant resources and partnership with some UK NHS hospitals and Tier 3 Chinese hospitals to implement the clinical research in wide therapeutic areas.
LCPS will work with our clients to closely monitor personnel ensure that the most up to date procedures and strict quality control are adhered to while working with the latest technology. Dedicated local line managers recruit, train and manage clinical monitoring staff to global standards and monitor quality to ICH-GCP, the clinical study protocol, client specific requests with internationals Standard Operating Procedures.

 
HOME ABOUT US SERVICES PARTNERSHIP CONTACT US
Copyright © 2011 Link China Solutions Ltd. All rights reserved.